Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125240504 | 12524050 | 4 | F | 20160618 | 20160916 | 20160704 | 20160923 | EXP | AR-ALEXION PHARMACEUTICALS INC.-A201604849 | ALEXION | 63.00 | YR | F | Y | 0.00000 | 20160923 | CN | AR | AR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125240504 | 12524050 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, QW | D | 125166 | 600 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | |||||
| 125240504 | 12524050 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | D | P0004801 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||
| 125240504 | 12524050 | 3 | C | WARFARIN | WARFARIN | 1 | Unknown | 0 | |||||||||||
| 125240504 | 12524050 | 4 | C | ERYTHROPOIETIN | ERYTHROPOIETIN | 1 | Unknown | 0 | |||||||||||
| 125240504 | 12524050 | 5 | C | DEFERASIROX | DEFERASIROX | 1 | Unknown | 0 | |||||||||||
| 125240504 | 12524050 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125240504 | 12524050 | 1 | Paroxysmal nocturnal haemoglobinuria |
| 125240504 | 12524050 | 3 | Product used for unknown indication |
| 125240504 | 12524050 | 4 | Product used for unknown indication |
| 125240504 | 12524050 | 5 | Product used for unknown indication |
| 125240504 | 12524050 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125240504 | 12524050 | OT |
| 125240504 | 12524050 | HO |
| 125240504 | 12524050 | DE |
| 125240504 | 12524050 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125240504 | 12524050 | Bradycardia | |
| 125240504 | 12524050 | Cardiac arrest | |
| 125240504 | 12524050 | Gastrointestinal haemorrhage | |
| 125240504 | 12524050 | Multiple organ dysfunction syndrome | |
| 125240504 | 12524050 | Pneumonia | |
| 125240504 | 12524050 | Renal impairment | |
| 125240504 | 12524050 | Respiratory failure | |
| 125240504 | 12524050 | Sensory disturbance | |
| 125240504 | 12524050 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125240504 | 12524050 | 1 | 20100116 | 0 | ||
| 125240504 | 12524050 | 2 | 20160712 | 0 |